Global Polymerase Chain Reaction Technologies Industry valued approximately USD 7 million in 2016 is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2019-2025. It is a medical device which is used for genetic engineering, genetics and molecular biology research. Increasing geriatric population, growing diagnostic centers and hospitals, rising prevalence of infectious diseases, advance technologies and increasing awareness personalized medicine are the major factors which drives the Industry growth. Minimize various PCR processes makes this one less tedious and may open various opportunities for this Industry. Furthermore, rising in funding for Research & Development activities and presence of major Industry players in developing countries are expected to provide new opportunity for the Industry in near future.
The objective of the study is to define Industry sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Industry. Additionally, the report shall also incorporate available opportunities in micro Industrys for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
Polymerase Chain Reaction Technologies Industry Share and Size by 2019-2025
Polymerase Chain Reaction Technologies Market Segmentation:
* Real-Time PCR
* Traditional PCR
* Digital PCR
* Reagents & Consumers
* Diagnostics Centre & Hospital
* Biotech & Pharma Companies
* Academic & Research Institution
* North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
Major Market Players in Polymerase Chain Reaction Technologies Market are as follows:
Bio-Rad Laboratories, Inc.,
Hoffmann-La Roche AG(ROCHE)
Tarkara Bi - Inc.
Therm - Fisher Scientific Inc.